A new rational approach to reach LDL-cholesterol concentration objectives after an acute coronary syndrome

Núria Ribas, Lluís Recasens, Silvia Pérez, Víctor Bazán, Juan Pedro-Botet, Sonia Ruiz, Roberto Elosua, Julio Martí-Almor

Research output: Contribution to journalArticleResearch

7 Citations (Scopus)


© 2018 Introduction and objectives: Adequate LDL cholesterol (LDLc) control after an acute coronary syndrome (ACS) is a crucial secondary prevention strategy to minimize the incidence of recurrent myocardial infarction and cardiovascular death. There are tables that predict the necessary dosage of lipid-lowering treatment from the initial LDLc but have not been tested in ACS. Variables associated with optimal LDLc after an ACS were analyzed and the therapeutic yield of the use of Masana's recommendations in this setting. Methods: A total number of 326 ACS-patients were included between January-2015 and May-2016. Baseline LDLc concentration and prescribed hypolipemiant treatment at hospital discharge were registered. We analyzed the variables associated with optimal LDLc levels (< 70 mg/dL) control during follow-up. Results: Among our patient population (72% male, age 66 ± 13 years), the hypolipemiant treatment at hospital discharge fulfilled the Masana's recommendations in 196 (60%) patients. After a follow-up period of 122 [66-184] days the targeted LDLc levels were achieved in 148 (45%) patients, being this percentage greater among those in whom the Masana's recommendations were fulfilled (109/196, 56%), as compared with the remaining (39/130, 30%; P <.001). The male gender (P <.001), the absence of prior history of dyslipemia (P <.001) and the adherence to Masana's recommendations (P =.007) were independent predictors for the achievement of targeted LDLc levels during follow-up. Conclusions: In less than half of ACS-patients adequate mid-term LDLc control is obtained. The dosage of the lipid-lowering therapy according to Masana's recommendations helps to achieve this important therapeutic goal.
Original languageEnglish
Pages (from-to)93-100
JournalClinica e Investigacion en Arteriosclerosis
Publication statusPublished - 4 Feb 2019


  • Acute coronary syndrome
  • Dyslipemia
  • LDL-cholesterol
  • Masana's recommendations
  • Secondary prevention
  • Statins
  • Cholesterol, LDL/blood
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Male
  • Treatment Outcome
  • Secondary Prevention/methods
  • Hypolipidemic Agents/administration & dosage
  • Acute Coronary Syndrome/prevention & control
  • Sex Factors
  • Aged, 80 and over
  • Female
  • Aged


Dive into the research topics of 'A new rational approach to reach LDL-cholesterol concentration objectives after an acute coronary syndrome'. Together they form a unique fingerprint.

Cite this